KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.9800
+0.0400 (+4.26%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close0.9400
Open0.9700
Bid0.9600 x 0
Ask0.9800 x 0
Day's Range0.9500 - 1.0500
52 Week Range0.7900 - 4.3500
Volume750,961
Avg. Volume511,001
Market Cap107.075M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.4100
Earnings DateMay 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.33
  • CNW Group

    Khiron Director and 55th President of Mexico, Vicente Fox to Present Keynote at UK Cannabis Investor Conference

    TORONTO, Nov. 21, 2019 /CNW/ -  Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that Company Director and 55th President of Mexico, Vicente Fox, will present a keynote address at the Bryan, Garnier & Co Cannabis Conference, taking place on Thursday, November 28, 2019 in London, UK.

  • CNW Group

    View from the C-Suite: Tejinder Virk, President, Khiron Life Sciences Corp., tells his company's story. Filmed on October 16, 2019

    View from the C-Suite: Tejinder Virk, President, Khiron Life Sciences Corp., tells his company's story. Filmed on October 16, 2019

  • CNW Group

    View from the C-Suite: Franziska Katterbach, Chief Legal Officer, Khiron Life Sciences Corp. Europe, tells her company's story. Filmed on October 16, 2019

    TORONTO , Nov. 20, 2019 /CNW/ -   https://www.youtube.com/watch?v=eWAWlCVmecM The View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange ...

  • CNW Group

    Khiron to be Exclusive Latin American Provider to Project Twenty21, Europe's Largest Medical Cannabis Study with 20,000 Patients

    Khiron to be Exclusive Latin American Provider to Project Twenty21, Europe's Largest Medical Cannabis Study with 20,000 Patients

  • CNW Group

    Khiron Launches Kuida Brand in the US, Begins First Sales

    TORONTO, Nov. 18, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced the official launch of the Company's Kuida brand in the United States. Beginning this Wednesday, November 20, Kuida's line of CBD skincare products will become available for purchase to US consumers at retail, initially in Los Angeles, before a planned expansion in priority US states where sale of hemp-derived CBD is permitted.

  • Market Exclusive

    Khiron Gets Approval to Bring Aceso Hemp Brand to Colombia

    Khiron Life Sciences (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) is preparing to launch the Aceso Hemp brand in the Latin America market. Aceso will be the first brand to enter the Latin America market under the company's joint venture with Dixie Brands Inc. (CSE: Dixi.U). The company has received approval to sell Aceso Hemp in Colombia, […]The post Khiron Gets Approval to Bring Aceso Hemp Brand to Colombia appeared first on Market Exclusive.

  • CNW Group

    Khiron Receives Approval to Sell Aceso™ Hemp CBD Brand in Colombia

    First Hemp CBD brand to enter Latin American market under Dixie Brands joint venture Builds on proven Aceso brand acceptance across US consumer market Product line includes indication-specific (heat and ...

  • CNW Group

    Khiron Enters First Latin American Cannabis Lines of Research Targeting U.S. $44 Billion Dermatological Drug Market

    Lines of research presented November 2, 2019 at II TeraCILAD dermatological conference with more than 1,000 LATAM dermatologists in attendance. Global dermatological (prescription) drug market valued at $38.4bn in 2017, rising to $44.1bn in 2018 (Source:GMR Data).

  • CNW Group

    Khiron Appoints Veteran Independent Director Deborah Rosati FCPA, FCA, ICD.D

    TORONTO, Nov. 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that Mark Monaghan has resigned as a director of the Company and that Deborah Rosati FCPA, FCA, ICD.D has been appointed effective immediately to the Board of Directors of the Company. Ms. Rosati has over 30 years of experience in leading and managing high growth companies and joins the Board, effective immediately.

  • CNW Group

    Khiron To Participate in Cowen 2nd Annual Boston Cannabis Conference

    TORONTO, Nov. 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce its participation in the Cowen 2nd Annual Boston Cannabis Conference, taking place Tuesday, November 12th to Wednesday, November 13th, 2019 in Boston, MA.

  • CNW Group

    Khiron to Host Live Investor Webcast on November 5, 2019

    TORONTO, Oct. 31, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce that Khiron President, Chris Naprawa, will present live at Grit Capital's Webcast Series on November 5th, 2019 at 11:00am ET/8:00am PT. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America.

  • Market Exclusive

    Cannabis Stock News Weekend Roundup October 27

    Flower One Holdings (CSE: FONE) (OTCQX: FLOOF) has announced that its brand partner has become the top-performing cannabis flower brand in Nevada. According to Headset, a cannabis industry analytics services provider, Old Pal is now the top-performing cannabis flower brand in Nevada. Flower One is licensed to produce and distribute the entire Old Pal product line. MYM […]The post Cannabis Stock News Weekend Roundup October 27 appeared first on Market Exclusive.

  • Baystreet

    Stocks in play: Khiron Life Sciences Corp.

    Announced today that, after a successful first year in the Colombian market, the Company adds another ...

  • Kuida is One Year Old! First Export to the US market, UK Product Approval, and 300+ Points of Sale in Colombia
    CNW Group

    Kuida is One Year Old! First Export to the US market, UK Product Approval, and 300+ Points of Sale in Colombia

    TORONTO, Oct. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that, after a successful first year in the Colombian market, the Company adds another significant milestone: its first import of Kuida cosmetic products into the United States. With this first shipment complete, Kuida has become the first Colombian brand to introduce legal CBD products in the US market.

  • CNW Group

    Khiron Participates in Mexican Senate Cannabis Regulation Forum

    Mexico poised to become the largest market in the world to fully legalize cannabis nationwide Forum with industry leaders to guide legislation to legalize both adult-use and medical cannabis in Mexico ...

  • CNW Group

    Khiron to Commercialize Kuida® Brand in U.K.

    Kuida is the first CBD skincare portfolio of products launched in Colombia from a federally approved cannabis company Company has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida® ...

  • CNW Group

    Khiron to Participate at BMO & TMX Hemp & Medical Cannabis Conference in London, UK

    TORONTO, Oct. 8, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference, taking place in in London, UK on October 16, 2019. Alvaro Torres, Khiron CEO and director will present at the conference, and Franziska Katterbach, Khiron Chief Legal Officer (Europe) will participate in a regulatory panel. The Company will also be available for pre-scheduled one-on-one meetings during the conference.